Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/1995
10/12/1995WO1995025509A3 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity
10/12/1995WO1995022639A3 Process for producing coated polymer microparticles
10/12/1995DE4411993A1 Tasty balls for pets to chew for combatting bad breath
10/12/1995CA2186962A1 Antibacterial therapy with genotypically modified bacteriophage
10/12/1995CA2186863A1 Heterofunctional, mucoadhesive dosage form
10/12/1995CA2186785A1 Process for producing sustained-release tablets and enteric tablets
10/12/1995CA2186734A1 Ophthalmic composition with decreased viscosity
10/12/1995CA2186604A1 Permanently ionic derivatives of steroid hormones and their antagonists
10/12/1995CA2186591A1 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity
10/12/1995CA2186370A1 Use of mcp-1 for inducing ripening of the cervix
10/12/1995CA2184261A1 Alphavirus cdna vectors
10/11/1995EP0676408A1 Process for the production of antibacterial agents and their use
10/11/1995EP0676204A1 Combinations of an organic nitrate and a salicylate
10/11/1995EP0676198A1 Fungicidal compositions containing a combination of bifonazole and fluocinonide
10/11/1995EP0675720A1 Transdermal, multiphasic hormone replacement therapy
10/11/1995EP0675711A1 Atovaquone pharmaceutical compositions
10/11/1995EP0675710A1 Process for preparing controlled release pharmaceutical forms and the forms thus obtained
10/11/1995EP0675709A1 Freeze-dried emulsion containing an active substance
10/11/1995EP0675686A1 Granular agent for ruminants.
10/11/1995EP0665759A4 Dry powder inhaler.
10/11/1995EP0596908B1 Mouth-hygiene agent containing hydrogen peroxide stabilized by colloidal silver
10/11/1995EP0559682B1 Topical composition
10/11/1995CN1109785A Organopolysiloxane composition of gel-like apperarance, containing no gelling agent, which may be used in cosmetics and dermatology
10/11/1995CN1109781A Eye drops-type insulin liquor and producing process thereof
10/11/1995CN1109779A Once-granulating process of ginseng and bupleurum root particles for curing hepatitis
10/11/1995CN1109771A Ointment for curing burn and scald and producing process thereof
10/11/1995CN1109770A Borneol-toad venom ointment for repercussion and analgesic, Chinese-medical prescription thereof and preparing process
10/11/1995CN1109755A Antiviral, Highly water soluble, stable, crystalline salts of 2',3'-dideoxyinosine monohydrate 2',3',-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate
10/11/1995CN1109754A Argatroban consentrated aqueous solution
10/11/1995CN1109751A Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof
10/11/1995CN1109748A Rapamycin formulation for IV injection
10/11/1995CN1109747A Rapamycin formulation for IV injection
10/11/1995CN1109746A Rapamycin formulations for oral administration
10/11/1995CN1109745A Ibuprofen-containing solid composition
10/11/1995CN1109744A Soft viaminate capsule and producing process thereof
10/11/1995CN1109743A Controlled release-initiation and controlled release-rate pharmaceutical composition
10/11/1995CN1109742A Toothpaste for health of cardio-cerebral blood vessel
10/11/1995CN1109741A Cosmatic and/or dermal composition containing salicylic acid
10/11/1995CN1029967C New xanthine derivatives
10/11/1995CN1029935C Pharmaceutical preparation and process for same
10/10/1995US5457117 Method for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[B][2-(piperidin-1-yl)ethoxyphenylimethanone hydrochloride
10/10/1995US5457093 Gel formulations containing growth factors
10/10/1995US5456985 Microcapsules of oily liquid
10/10/1995US5456941 Process for preparing biodegradable water-resistant film and method for rendering biodegradable article water-resistant
10/10/1995US5456932 Adding fructose to reduce heat needed to create flash flow conditions
10/10/1995US5456925 Salt of ranitidine and complex of bismuth and tartaric or citric acid with alkaline salt; improved disintegration or dissolution
10/10/1995US5456923 Method of manufacturing solid dispersion
10/10/1995US5456922 Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
10/10/1995US5456921 Epichlorohydrin or dibromopropanol/2,3-/ used as crosslinker for amylose matrix as sustained release matrix
10/10/1995US5456920 Uncoated tablets and method of producing the same
10/10/1995US5456918 Ranitidine pharmaceutical compositions
10/10/1995US5456917 Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
10/10/1995US5456915 Moisturizers containing 3-methyl-1,3-butanediol and 1,3-butanediol; higher moisturizing efficacy
10/10/1995US5456901 Administering liposome having encapsulated contrast enhancing agent, scanning patient using ultrasonic imaging
10/10/1995US5456900 Low density microspheres and their use as contrast agents for computed tomography
10/10/1995US5456746 Gelatin containing ester of fatty acid and glycerol; reduces cracking, chipping, leakage of capsules
10/10/1995US5456745 Anion-active, and cation-active water soluble polymer, moisturizer, water, auxiliaries, active substance
10/10/1995US5456679 Use for the pulsatile delivery of a beneficial agent
10/10/1995US5456677 Method for oral spray administration of caffeine
10/10/1995US5456247 Method for delivering drugs soluble in a vaporization vehicle
10/10/1995CA1337279C Intravaginal treatment of vaginal infections with buffered metronidazole compositions
10/10/1995CA1337275C Aqueous based pharmaceutical coating composition for dosage forms
10/10/1995CA1337274C Enteric film and preparation thereof
10/10/1995CA1337273C Method for size separation of particles
10/10/1995CA1337272C Drug adsorbates
10/10/1995CA1337270C Multilayer plaster
10/10/1995CA1337262C Time release protein
10/10/1995CA1337235C Chemical reactions in reverse micelle systems
10/06/1995CA2145968A1 Topical antipruritic composition
10/05/1995WO1995026408A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf)
10/05/1995WO1995026376A2 Polymer microspheres and a method of production thereof
10/05/1995WO1995026356A1 Novel cationic phospholipids for transfection
10/05/1995WO1995026202A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
10/05/1995WO1995026193A1 Use of hyaluronic acid and forms to prevent arterial restenosis
10/05/1995WO1995026191A1 Injectable solutions of dirithromycin
10/05/1995WO1995026186A1 Methods of administering n-substituted benzamides or phenothiazines
10/05/1995WO1995026185A1 Liposome with increased retention volume
10/05/1995WO1995026184A1 Process for producing a saponine foam, medical, cosmetic, germicide or parasiticide foaming agent, and use of the same
10/05/1995WO1995026158A1 Method and apparatus for diagnosing erectile dysfunction
10/05/1995WO1995026155A1 Pillowcase
10/05/1995WO1995026134A1 Composition for inactivating irritants in fluids
10/05/1995WO1995016452A3 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems
10/05/1995DE4411557A1 Verfahren zur Herstellung von Mikroemulsionen A process for the preparation of microemulsions
10/05/1995DE4410778A1 Verfahren zur Herstellung eines medizinisch, kosmetisch, keimabtötend oder parasitenabtötend wirkenden Mittels, sowie Mittel zur Durchführung des Verfahrens und Mittel hergestellt nach dem Verfahren sowie die Verwendung der hergestellten Mittel A method for producing a medical, cosmetic, germicidal or parasitenabtötend acting agent, and means for performing the method and means produced by the method and to the use of compositions prepared
10/05/1995CA2186745A1 Liposome with increased retention volume
10/05/1995CA2186390A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
10/05/1995CA2182952A1 Methods of administering n-substituted benzamides or phenothiazines
10/04/1995EP0674913A2 Non-occulusive adhesive patch for applying medication to the skin
10/04/1995EP0674903A1 Raloxifene for inhibiting bone loss and lowing serum cholesterol
10/04/1995EP0674901A1 Transdermal matrix system comprising a styrene-isoprene-styrene copolymer for the administration of an oestrogen and/or gestagen
10/04/1995EP0674900A1 Transdermal matrix system comprising EVA for the administration of an oestrogen and/or gestagen
10/04/1995EP0674646A1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
10/04/1995EP0674529A1 Lipid prodrugs for oral administration
10/04/1995EP0674528A1 Cyclodextrin and polymer based drug delivery system
10/04/1995EP0674525A1 Aqueous pharmaceutical preparations of g-csf with a long shelf life
10/04/1995EP0674524A1 Stable lyophilized pharmaceutical preparations g-csf
10/04/1995EP0674523A1 Topical composition containing garlic oil
10/04/1995EP0674522A1 Linseed mucilage
10/04/1995EP0674520A1 Application of carbamazepine and oxcarbazepine in the treatment of neurological lesions related to traumatic injuries
10/04/1995EP0674518A1 Application of lamotrigine in the treatment of neurological lesions related to traumatic injuries